Safety and Efficacy of Low-Dose Prednisolone with Pirfenidone in Idiopathic Pulmonary Fibrosis

被引:0
|
作者
Matsubayashi, S. [1 ]
Izumi, S. [1 ]
Takumida, H. [1 ]
Watanabe, H. [1 ]
Matsumoto, S. [1 ]
Kusaba, Y. [1 ]
Katsuno, T. [1 ]
Kakuwa, T. [1 ]
Tsujimoto, Y. [1 ]
Sakamoto, K. [1 ]
Hashimoto, M. [1 ]
Ishii, S. [1 ]
Morino, E. [1 ]
Suzuki, M. [1 ]
Takasaki, J. [1 ]
Naka, G. [1 ]
Iikura, M. [1 ]
Takeda, Y. [1 ]
Sugiyama, H. [1 ]
机构
[1] Natl Ctr Global Hlth & Med, Resp Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4769
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Long-Term Efficacy Of Pirfenidone For Idiopathic Pulmonary Fibrosis
    Bando, M.
    Yamauchi, H.
    Ogura, T.
    Taniguchi, H.
    Watanabe, K.
    Azuma, A.
    Homma, S.
    Sugiyama, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [42] Efficacy and adverse events of pirfenidone in treating idiopathic pulmonary fibrosis
    Ren, Hui
    Wang, Kai
    Yang, Hao
    Gao, Lingyun
    SAUDI MEDICAL JOURNAL, 2017, 38 (09) : 889 - 894
  • [43] Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study
    Hwang, Hyeontaek
    Lee, Jung-Kyu
    Choi, Sun Mi
    Lee, Yeon Joo
    Cho, Young-Jae
    Yoon, Ho Il
    Lee, Jae Ho
    Lee, Choon-Taek
    Kim, Young Whan
    Park, Jong Sun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (02): : 366 - 376
  • [44] Effectiveness and safety of pirfenidone used for treatment of idiopathic pulmonary fibrosis
    Gonzalez Sevilla, Marta
    Garcia Munoz, Carmen
    Ortiz Perez, Sara
    Lazaro Cebas, Andrea
    Fernandez Redondo, Delia
    Serrano Garrote, Olga
    Ferrari Piquero, Jose Miguel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 327 - 327
  • [45] Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
    Leceuvre, Katleen
    De Dycker, Els
    Moerman, Tom
    Yserbyt, Jonas
    Wuyts, Wim
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [46] Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study
    Tzouvelekis, Argyrios
    Ntolios, Paschalis
    Karampitsakos, Theodoros
    Tzilas, Vasilios
    Anevlavis, Stavros
    Bouros, Evangelos
    Steiropoulos, Paschalis
    Koulouris, Nikolaos
    Stratakos, Grigoris
    Froudarakis, Marios
    Bouros, Demosthenes
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 : 48 - 53
  • [47] Effects of low dose pirfenidone on lung function for patients with idiopathic pulmonary fibrosis in real practice
    Moon, K. M.
    Jung, B.
    Lee, J. G.
    Kim, M. P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [48] Pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Xaubet, Antoni
    Serrano-Mollar, Anna
    Ancochea, Julio
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 275 - 281
  • [49] Pirfenidone in idiopathic pulmonary fibrosis: Is there a role?
    Galal, I.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (04): : 749 - 750
  • [50] Pirfenidone treatment of idiopathic pulmonary fibrosis
    Gan, Ye
    Herzog, Erica L.
    Gomer, Richard H.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2011, 7 : 39 - 47